These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

833 related items for PubMed ID: 8718521

  • 1. Von Hippel-Lindau disease and sporadic renal cell carcinoma.
    Zbar B.
    Cancer Surv; 1995; 25():219-32. PubMed ID: 8718521
    [Abstract] [Full Text] [Related]

  • 2. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
    Clifford SC, Prowse AH, Affara NA, Buys CH, Maher ER.
    Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
    [Abstract] [Full Text] [Related]

  • 3. Von Hippel-Lindau gene alterations in sporadic benign and malignant pheochromocytomas.
    Dannenberg H, De Krijger RR, van der Harst E, Abbou M, IJzendoorn Y, Komminoth P, Dinjens WN.
    Int J Cancer; 2003 Jun 10; 105(2):190-5. PubMed ID: 12673678
    [Abstract] [Full Text] [Related]

  • 4. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
    Zatyka M, da Silva NF, Clifford SC, Morris MR, Wiesener MS, Eckardt KU, Houlston RS, Richards FM, Latif F, Maher ER.
    Cancer Res; 2002 Jul 01; 62(13):3803-11. PubMed ID: 12097293
    [Abstract] [Full Text] [Related]

  • 5. Role of VHL gene mutation in human cancer.
    Kim WY, Kaelin WG.
    J Clin Oncol; 2004 Dec 15; 22(24):4991-5004. PubMed ID: 15611513
    [Abstract] [Full Text] [Related]

  • 6. Renal cell carcinoma- and pheochromocytoma-specific altered gene expression profiles in VHL mutant clones.
    Tsuchiya MI, Okuda H, Takaki Y, Baba M, Hirai S, Ohno S, Shuin T.
    Oncol Rep; 2005 Jun 15; 13(6):1033-41. PubMed ID: 15870918
    [Abstract] [Full Text] [Related]

  • 7. Somatic von Hippel-Lindau disease gene mutation in clear-cell renal carcinomas associated with end-stage renal disease/acquired cystic disease of the kidney.
    Yoshida M, Yao M, Ishikawa I, Kishida T, Nagashima Y, Kondo K, Nakaigawa N, Hosaka M.
    Genes Chromosomes Cancer; 2002 Dec 15; 35(4):359-64. PubMed ID: 12378530
    [Abstract] [Full Text] [Related]

  • 8. Genotype-phenotype correlation in von Hippel-Lindau syndrome.
    Friedrich CA.
    Hum Mol Genet; 2001 Apr 15; 10(7):763-7. PubMed ID: 11257110
    [Abstract] [Full Text] [Related]

  • 9. The von Hippel-Lindau tumor suppressor gene and kidney cancer.
    Kaelin WG.
    Clin Cancer Res; 2004 Sep 15; 10(18 Pt 2):6290S-5S. PubMed ID: 15448019
    [Abstract] [Full Text] [Related]

  • 10. VHL alterations in human clear cell renal cell carcinoma: association with advanced tumor stage and a novel hot spot mutation.
    Brauch H, Weirich G, Brieger J, Glavac D, Rödl H, Eichinger M, Feurer M, Weidt E, Puranakanitstha C, Neuhaus C, Pomer S, Brenner W, Schirmacher P, Störkel S, Rotter M, Masera A, Gugeler N, Decker HJ.
    Cancer Res; 2000 Apr 01; 60(7):1942-8. PubMed ID: 10766184
    [Abstract] [Full Text] [Related]

  • 11. Molecular study of a new family with hereditary renal cell carcinoma and a translocation t(3;8)(p13;q24.1).
    Meléndez B, Rodríguez-Perales S, Martínez-Delgado B, Otero I, Robledo M, Martínez-Ramírez A, Ruiz-Llorente S, Urioste M, Cigudosa JC, Benítez J.
    Hum Genet; 2003 Feb 01; 112(2):178-85. PubMed ID: 12522559
    [Abstract] [Full Text] [Related]

  • 12. [Prevention of renal carcinoma: the nutri-genetic approach].
    Junien C, Dupret JM, Gallou C, Longuemaux S, Richard S, Saquet C, Krishnamoorty R, Delomenie C, Droz D, Bouvier R, Chauveau D, Joly D, Grunfeld JP, Chretien Y, Mejean A, Beroud C.
    J Soc Biol; 2000 Feb 01; 194(1):29-38. PubMed ID: 11107547
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients.
    Lubensky IA, Gnarra JR, Bertheau P, Walther MM, Linehan WM, Zhuang Z.
    Am J Pathol; 1996 Dec 01; 149(6):2089-94. PubMed ID: 8952541
    [Abstract] [Full Text] [Related]

  • 15. [Hippel-Lindau syndrome and sporadic renal cell carcinomas. Pathogenesis, morphologic spectrum and molecular genetics].
    Brauch H, Böhm J, Höfler H.
    Pathologe; 1995 Sep 01; 16(5):321-7. PubMed ID: 7479604
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan.
    Zbar B, Kishida T, Chen F, Schmidt L, Maher ER, Richards FM, Crossey PA, Webster AR, Affara NA, Ferguson-Smith MA, Brauch H, Glavac D, Neumann HP, Tisherman S, Mulvihill JJ, Gross DJ, Shuin T, Whaley J, Seizinger B, Kley N, Olschwang S, Boisson C, Richard S, Lips CH, Lerman M.
    Hum Mutat; 1996 Sep 01; 8(4):348-57. PubMed ID: 8956040
    [Abstract] [Full Text] [Related]

  • 18. Mutational analysis of the von hippel lindau gene in clear cell renal carcinomas from tuberous sclerosis complex patients.
    Duffy K, Al-Saleem T, Karbowniczek M, Ewalt D, Prowse AH, Henske EP.
    Mod Pathol; 2002 Mar 01; 15(3):205-10. PubMed ID: 11904337
    [Abstract] [Full Text] [Related]

  • 19. von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF.
    Hoffman MA, Ohh M, Yang H, Klco JM, Ivan M, Kaelin WG.
    Hum Mol Genet; 2001 May 01; 10(10):1019-27. PubMed ID: 11331612
    [Abstract] [Full Text] [Related]

  • 20. Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein.
    Siemeister G, Weindel K, Mohrs K, Barleon B, Martiny-Baron G, Marmé D.
    Cancer Res; 1996 May 15; 56(10):2299-301. PubMed ID: 8625303
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.